The largest database of trusted experimental protocols

Silastic tubes

Manufactured by Dow
Sourced in United States

Silastic tubes are flexible, non-reactive silicone-based tubes used in various laboratory applications. They are designed to withstand a range of temperatures and chemical exposures, making them suitable for fluid transfer, sampling, and other experimental setups.

Automatically generated - may contain errors

5 protocols using silastic tubes

1

Androgenizing Female Rats via Testosterone Implants

Check if the same lab product or an alternative is used in the 5 most similar protocols
One group of adult female rats was ovariectomized, 1 week after which they received testosterone implants. These remained in place for an additional 1 week, at which time i.t. cannulation and perfusion (see below) were performed. This method, previously used to androgenize gonadectomized adult rats, achieves circulating testosterone levels comparable to those of intact adult male rats (11.7 ± 4.7 ng/ml).70 (link),101 (link) In brief, Silastic laboratory tubing (Dow Corning, Midland, MI) was used for testosterone implants, which consisted of two Silastic tubes (i.d. 0.20 cm, o.d. 0.32 cm, length 3 cm) packed with testosterone (Steraloids, Inc., Newport, RI) and sealed with A-100 Medical Silicone Adhesive (Factor II, Inc., Lakeside, AZ). Implants were submerged in 0.9% saline solution at 37°C for 24 ho urs, and then implanted subcutaneously 3 cm distal to the shoulder blade (under 2.5% isoflurane anesthesia).
+ Open protocol
+ Expand
2

Silastic Tube Testosterone Implantation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To stimulate hyperandrogenemia, the silastic tubes (I.D. 1.98 mm × O.D. 3.18 mm; Dow Corning, Midland, MI, USA) were used along with the implantable osmotic pump (Durect Corporation, Curpertino, CA, USA) filled with DHT as described earlier [18 (link)]. The osmotic pump releases the controlled, predetermined level of DHT (3.46 µg/h) based upon the osmotic pressure difference between the osmotic layer and the tissue environment.
+ Open protocol
+ Expand
3

Silastic Implants for Hormone Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
To minimize the stress of injections and the fluctuations in plasma levels of hormones associated with bolus steroid injections, hormones were replaced using Silastic implants. These are prepared according to the method described by Legan et al.(1975) (link), and modified according to Febo et al.(2002) (link). The Silastic tubes (Dow Corning, Midland, MI, USA) had an internal diameter of 1.47 mm and an external diameter of 1.97 mm (“membrane thickness” of 0.5 mm). For estradiol administration, the length of the Silastic tubes was 5 mm (volume = 8.49 mm3). For DHT administration we used 2 Silastic implants, each measuring 10 mm in length (total volume = 16.97 mm3). Implants were empty (GDX) or filled with gonadal steroids and sealed on both ends with Room Temperature Vulcanizing (RTV) Silicone Sealant (Dow Corning, Midland, MI, USA). Hormones were purchased from Sigma-Aldrich (St. Louis, MO, USA). Implants were placed subcutaneously in the midscapular region during surgery and remained there throughout the experiments. Silastic implants were used instead of commercially available steroid pellets. Our previous studies agree with that of others that report a better and more consistent release from Silastic tubes (Strom et al. 2008; Ingberg et al. 2012 (link)) than from commercially available pellets.
+ Open protocol
+ Expand
4

Estradiol-Filled Silastic Implant Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Silastic tubing implants were prepared according to Legan et al. and modified according to Febo et al. [18 (link),19 (link)]. Briefly, 5 mm Silastic tubes (1.47 mm internal diameter, 1.97 mm outside diameter; Dow Corning, distributed by Fisher Scientific, Cayey, Puerto Rico) were filled with 3, 4 and 5 mg of 17-β-estradiol 3-benzoate (Sigma-Aldrich, St. Louis, MO, USA) or left empty. These tubes were sealed at each end with sterile silicone adhesive sealant. Silastic implants were placed in a 0.9% sterile saline solution 3 hrs prior to use to confirm the integrity of the tubes. Those that did not float at the end of this period were discarded. Commercial pellets of 17-β-estradiol (3 mg and 4 mg) were purchased from Innovative Research (Sarasota, FL) to compare its delivery efficiency with that of the estradiol-filled Silastic tubing. Placebo pellets composed of cholesterol and other “inert” ingredients (personal communication) were purchased to use as controls. All implants were inserted in the midscapular region immediately after ovariectomy to reduce alterations in the physiology of the animal, such as the increase in appetite, weight and anxiety among others.
+ Open protocol
+ Expand
5

Estrogen Administration in Male Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chronic administration of estrogen in male rats was performed as described previously by Smith and colleagues (Smith et al., 1977 ). Briefly, 17β-estradiol [from Sigma-Aldrich (St. Louis, MO, USA)] was administered by implanting estrogen filled Silastic tubes [(I.D. 1.57 mm, O.D. 3.18 mm) of 5 mm effective length; Dow Corning, Midland, MI, USA)]. The ends of the implants were sealed with silicone rods (Goodfellow, Cambridge, UK). Implants were then washed in ethanol and equilibrated in four changes of warm phosphate-buffered saline over a 24-h period before placement in the rat. Under inhalation anesthesia, isoflurane (2.5%; Phoenix Pharmaceuticals, St. Joseph, MO, USA) in 97.5% O2, six male rats were treated with 0.5% of bupivacaine at the incision site and an intramuscular injection of carprofen (5 mg/kg). Implants were placed subcutaneously on the rat’s back, at the time of surgery (Smith et al., 1977 ). Implants were placed 2 weeks before sumatriptan (1 ng) was injected intradermally on the dorsum of the hindpaw.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!